Southern Symposium on Foregut Cancers
Symposium Webcasts
Welcome Address and Opening
| Speaker | Affiliation | Presentation | |
| Dr Susan O Reilly | Director, National Cancer Control Programme | Progress in Cancer Care: Colorectal Perspective |  |
Controversies in Colorectal Cancer
| Speaker | Affiliation | Presentation | |
| Mr Garrett Nash | Consultant Colorectal Surgeon, Memorial Sloan Kettering Cancer Center, New York | Peritoneal Carcinomatosis: What is the Optimal Treatment? The Surgery Perspective | |
| Professor Phil Quirke | Professor of Pathology, School of Medicine, University of Leeds, UK | What is Bad Prognosis Stage II Colon Cancer? What Your Pathologist Can Tell You | |
| Prof David Sebag Montefiore | Professor of Clinical Oncology, University of Leeds, UK | FOR: A DEBATE : ‘T3 Rectal Cancer in the Era of TME: What is the Optimal Treatment?’ | |
| Mr Myles Joyce | Consultant Surgeon, Galway University Hospital, Galway | AGAINST: A DEBATE : ‘T3 Rectal Cancer in the Era of TME: What is the Optimal Treatment?’ | |
| Dr. Brian O'Neill | Consultant Radiation Oncologist, St Luke’s & Beaumont Hospitals, Dublin. | Short Course Radiotherapy VS Long Course Chemoradiotherapy for Rectal Cancer | |
Updates in the Surgical Management of Colorectal Cancer
| Speaker | Affiliation | Presentation | |
| Mr Mícheál Ó Ríordáin | Consultant Colorectal Surgeon, Mercy University Hospital, Cork. | Laparoscopic Surgery for Colorectal Cancer | |
| Mr David Jayne | Senior Lecturer, University of Leeds/Consultant Surgeon, Leeds Teaching Hospitals NHS Trust, UK. | Robotic Surgery for Colorectal Cancer | |
| Dr Derek Power | Consultant Medical Oncologist, Mercy University Hospital, Cork. | Inherited Colorectal Cancer Syndromes - Who Should be Tested? | |
| Dr John L Marshall | Chief, Hematology and Oncology / Professor of Medicine and Oncology / Associate Director of Clinical Research / Director, Otto J Ruesch Center for the Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Center, Georgetown University, Washington. | KEY NOTE SPEAKER Managing Colon Cancer in the Era of Personalised Medicine |
|
Day 2: Welcome Address
| Speaker | Affiliation | Presentation | |
| Professor Graeme Poston | Consultant Hepato-biliary Surgeon, University Hospital Aintree, Liverpool, & Professor of Surgery of the University of Liverpool, UK. | An Overview: Improved Survival in Metastatic Colorectal Cancer is Associated with Adoption of Hepatic Resection and Chemotherapy | |
Imaging
| Speaker | Affiliation | Presentation | |
| Professor Dushyant V Sahani | Director of CT, Associate Professor of Radiology, Harvard Medical School, Massachusetts General Hospital, Boston, USA | The Role of Cross Sectional Imaging and Ultrasound in Liver Resection and Follow Up | |
| Dr Kevin O’Regan | Consultant Radiologist, Cork University Hospital, Cork | Is Metabolic Imaging Prior to Liver Resection Necessary? | |
Surgery
| Speaker | Affiliation | Presentation | |
| Professor David C Linehan | Chief, Division of General Surgery, Section of Hepatobiliary-Pancreatic and Gastrointestinal Surgery, Washington University Cancer Centre, St. Louis, USA | Definitions of Resectability and the Evolution of Surgical Strategies | |
| Professor Maria B. Majella Doyle | Assistant Professor of Surgery and Director of the HPB Fellowship Program, Division of General Surgery, Section of Abdominal Transplantation, Washington University in St Louis | Synchronous or Metachronous Resection of Liver Metastases and Primary Colorectal Cancer | |
| Professor Michael I D’Angelica | Department of Surgery, Hepatopancreaticobiliary Service, Memorial Sloan Kettering Cancer Centre, New York, USA | Resection of Extrahepatic Disease: Why and When? | |
Systemic Chemobiologic Therapy
| Speaker | Affiliation | Presentation | |
| Dr Geoff Ku | Attending Medical Oncologist, Dept of Gastrointestinal Oncology Memorial Sloan Kettering Cancer Centre, New York, USA | Anti-EGFR Therapies: The more we know... | |
| Dr Neil Segal | Attending Medical Oncologist, Dept of Gastrointestinal Oncology, Memoial Sloan Kettering Cancer Centre, 4 New York, USA | Evolution of Systemic Therapy with a Focus on Anti-Angiogenic Strategies and Beyond | |
| Professor Aimery De Gramont | Head of the Medical Oncology Service, Hopital Saint-Antoine, Paris, France | New Paradigms for the Treatment of Metastatic Colorectal Cancer (MCRC) | |
Regional Therapy
| Speaker | Affiliation | Presentation | |
| Professor Nancy E Kemeny | Attending Medical Oncologist, Department of Medicine, Gastrointestinal Oncology, Service, Memorial Sloan Kettering Cancer Centre, New York, USA | Hepatic Arterial Infusion in Liver Resection – State of the Art | |
| Dr Richard A Sharma | Consultant Clinical Oncologist, Department of Radiation Oncology, University of Oxford, Churchill Hospital, Oxford, UK | Yttrium-Labeled Microspheres | |
| Mr Emir Hoti | Consultant Hepatopancreaticobiliary Surgeon, Department of Surgery, St Vincent’s University Hospital, Dublin | Ablative Therapies | |